Purchase Order 75D30122P13911
Award Date
6/1/22
Potential Completion Date
9/30/23
Potential Value
$25K
Federal Agency
CDC Pittsburgh
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $60,250.00 firm fixed price purchase order contract to Qiagen, LLC, a division of the parent company Qiagen N.V. The contract has an ultimate completion date of September 28, 2024 and was awarded on September 29, 2023. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academics. This contract does not have a set-aside designation. Qiagen has...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $148,000.00 contract is for the delivery of products and services to support the CDC's biomedical research, public health, and healthcare programs. This includes DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, bioinformatics...
This is a $14,288 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of Qiagen N.V. The contract has a period of performance from April 1, 2025 to March 31, 2026 for Qiagen to provide laboratory services under the IP0023 Statement of Work. No set-aside designation was used. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, and other applications. The company...
This is a $145,237 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract is for "other functions" and does not have a set-aside designation. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. Under this award, Qiagen is likely providing products and services to support the...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the acquisition of QIAGEN equipment and reagents. The contract, valued at $134,538.38, does not have a set-aside designation. Qiagen N.V. is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. The company has a history of supporting federal...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $38,760.96 contract is for laboratory supplies to be delivered by November 1, 2022. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under past...
The Centers for Disease Control and Prevention awarded a firm fixed price purchase order valued at thirty-two thousand two hundred four dollars and twenty-seven cents ($32,204.27) to Qiagen, LLC for sequencing next generation services and RNA quality control. The contract has no set-aside designation. Performance will take place in Germantown, Maryland through July 2024. The original solicitation sought these sequencing and quality control services from Qiagen at their Germantown location on a...
This is a $148,157.70 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for other unspecified functions and does not have a set-aside designation. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Qiagen, LLC for a PYROMARK Q48 SYSTEM with a completion date of July 20, 2019 and a potential value of $139,884.28. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies. Qiagen has provided a range of products and services, including DNA/RNA extraction kits, next-generation sequencing, and precision medicine...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $55,000.00 firm fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. This contract has a completion date of May 21, 2024. Qiagen is a foreign-owned, for-profit manufacturer that has provided a range of products and services to support federal...